Oct 16, 2020 4:48pm EDT

IMV Inc. Re-establishes At-the-Market Facility

Oct 15, 2020 7:05am EDT

Biomarkers Associated With Clinical Response in Patients With r/r DLBCL Treated With DPX-Survivac Combination Therapy to be Presented at the Upcoming Annual SITC Meeting

Oct 08, 2020 7:05am EDT

IMV Provides Updates On COVID-19 Vaccine Program

Sep 16, 2020 7:05am EDT

IMV CEO to Participate at the Vaccines Panel of the Sachs Associates 20th Annual Biotech in Europe Forum

Aug 26, 2020 7:05am EDT

IMV to Participate at Four Upcoming Investor Conferences

Aug 12, 2020 7:05am EDT

IMV Inc. Announces Second Quarter 2020 Financial Results

Aug 05, 2020 7:05am EDT

IMV Receives Funding From Canadian Governmental Agencies for COVID-19 Vaccine Phase 1 Clinical Study

Aug 03, 2020 7:05am EDT

IMV Inc. to Announce Second Quarter 2020 Results and Host a Conference Call and Webcast on August 12, 2020

Jul 29, 2020 7:05am EDT

IMV to Present at BTIG’s Virtual Biotechnology Conference

Jul 20, 2020 7:05am EDT

IMV Announces Appointment of Michael P. Bailey to Board of Directors